Colorectal Cancer
Liquid biopsy not cost-effective as alternative to colonoscopy for CRC screening
The cost of liquid biopsy for second-line colorectal cancer screening was not cost-effective and would have to be reduced by 66% to increase uptake among the general population, according to data in JAMA Network Open.
‘Small difference’ in colorectal neoplasia recurrence at 5 vs. 10 years after polypectomy
Study findings support performing surveillance colonoscopy 7 to 10 years after detection and polypectomy of baseline non-advanced adenoma rather than at 5 years, researchers wrote in the Journal of Gastroenterology and Hepatology.
Recommended exercise leads to 'fairly profound' mortality reduction for cancer survivors
For individuals diagnosed with cancer, guideline-concordant exercise reduced all-cause mortality by 25% compared with patients with cancer who did not exercise, study results published in Journal of Clinical Oncology showed.
Study: White bread, alcohol may increase risk for colorectal cancer
Consuming high amounts of white bread and alcohol were linked to an increased risk for colorectal cancer, a recent study in Nutrients showed. Meanwhile, fiber, magnesium and other dietary components were associated with a reduced risk.
Oncologists encouraged to ‘look within’ to promote cancer care equity for LGBTQ+ patients
Substantial progress has been made in decreasing cancer care disparities among sexual and gender minorities since ASCO’s 2017 position statement on the subject, according to a report published in JCO Oncology Practice.
Study reveals ‘substantial drop’ in cancer treatments during start of COVID-19 pandemic
The number of cancer surgeries, chemotherapy treatments and radiation treatments declined dramatically during the first months of the COVID-19 pandemic, study findings published in JAMA Oncology showed.
Stool-based colorectal cancer testing produces a high proportion of unsatisfactory samples
Over 10% of fecal immunochemical tests used for routine colorectal cancer screening contained unsatisfactory samples that could not be processed, according to study findings published in Cancer Epidemiology, Biomarkers and Prevention.
Type 2 diabetes associated with higher risk for colorectal cancer
Risk for developing colorectal cancer increased by 47% among individuals with type 2 diabetes, according to results from a cohort study designed to over-represent African Americans and low-income patients.
FDA approves Fruzaqla for treatment of refractory metastatic colorectal cancer
The FDA approved fruquintinib for certain adults with previously treated metastatic colorectal cancer.
Analysis: 10 periprocedural interventions improve adenoma detection during colonoscopy
VANCOUVER, British Columbia — Results from a systematic review and network meta-analysis showed 10 interventions, including dual observation, iScan and G-EYE, improved adenoma detection rate during screening-related colonoscopy.